Zhejiang University School of Medicine in China, along with American researchers, has found no link between late-life intake ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the successful de ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

A breakthrough clinical trial in Japan reveals that a vitamin B3 derivative significantly improves symptoms of the rare ...

GRAND RAPIDS, MI, USA I June 20, 2025 I Cirius Therapeutics, Inc., a developer of innovative therapies for patients suffering from diseases caused by ...

GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

Diabetes is increasing due to obesity and lack of exercise, and if type 2 diabetes patients are accompanied by mental illness ...

Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...

Alex Kent Hi, my name’s Alex Kent. I’m medical director for North East and North Cumbria ICB and I cover long term conditions as part of my portfolio. I also work part time as a GP in North Tyneside.

With tremendous social and economic costs, dementia is now the seventh leading cause of death globally, affecting 57 million ...